Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figure Technology Solutions Inc. Class A Common Stock (FIGR) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

Figure Technology Solutions Inc. Class A Common StockTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Figure Technology Solutions Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.02 (market cap $6.21B), while Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.9× Figure Technology Solutions Inc. Class A Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

FIGRRVMD
Market Cap
$6.21B$43.07B
Volume
4,025,1821,184,841
Sector
FinancialsHealth
52-Week High
$73.91$221.15
52-Week Low
$24.91$47.50
Typical Hold Time
0 Days0 Days
Enterprise Value
$6.24B$39.77B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIGR
100% Buy0% Sell
Avg holding period · 0 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

About Figure Technology Solutions Inc. Class A Common Stock

Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.

Read more on FIGR →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →